JMP Group (NYSE:JMP) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday, Zacks.com reports.
According to Zacks, “JMP GROUP INC. is a full-service investment banking and asset management firm that provides investment banking, sales and trading, and equity research services to corporate and institutional clients and alternative asset management products to institutional and high-net-worth investors. JMP Group operates through two subsidiaries, JMP Securities and JMP Asset Management. The company focuses its resources on small and middle-market growth companies and the institutions that invest in them. They approach their work with the idea that expertise, intellectual capital and relationships can never be commoditized. “
JMP has been the topic of several other research reports. TheStreet upgraded JMP Group from a “d” rating to a “c-” rating in a research report on Monday, December 14th. Barrington Research reissued an “outperform” rating on shares of JMP Group in a report on Monday, November 2nd.
Shares of JMP Group stock opened at $3.93 on Tuesday. The firm’s fifty day simple moving average is $3.35 and its 200-day simple moving average is $2.78. JMP Group has a 12 month low of $2.15 and a 12 month high of $4.00. The stock has a market capitalization of $77.29 million, a price-to-earnings ratio of -3.82, a PEG ratio of 1.01 and a beta of 0.91. The company has a debt-to-equity ratio of 1.52, a current ratio of 1.93 and a quick ratio of 1.93.
JMP Group (NYSE:JMP) last issued its quarterly earnings data on Wednesday, October 28th. The financial services provider reported $0.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.05 by $0.05. JMP Group had a negative net margin of 23.51% and a positive return on equity of 7.71%. The company had revenue of $26.62 million for the quarter, compared to the consensus estimate of $22.80 million. Analysts anticipate that JMP Group will post 0.35 earnings per share for the current year.
If you think these huge trades are options – they’re not.
Even better, these trades can cost 25¢…10¢…even as little as ONE PENNY a pop.
PLUS, an elite group of our readers just saw a 19¢ recommendation soar as much as an extraordinary 5,100%.
And, thanks to an obscure loophole in SEC Rule 30.52…
You can place these weird trades right from your brokerage account.
In other JMP Group news, Director Craig R. Johnson bought 11,895 shares of the business’s stock in a transaction dated Friday, November 20th. The stock was acquired at an average cost of $2.65 per share, with a total value of $31,521.75. Following the purchase, the director now owns 367,912 shares in the company, valued at approximately $974,966.80. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Craig R. Johnson purchased 10,000 shares of JMP Group stock in a transaction dated Wednesday, November 25th. The stock was acquired at an average cost of $2.98 per share, with a total value of $29,800.00. Following the completion of the acquisition, the director now directly owns 367,912 shares in the company, valued at $1,096,377.76. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 44,540 shares of company stock worth $128,732. Insiders own 58.67% of the company’s stock.
JMP Group Company Profile
JMP Group LLC, together with its subsidiaries, provides investment banking, sales and trading, equity research, and asset management products and services in the United States. The company operates through Broker-Dealer, Asset Management Fee Income, and Investment Income segments. It offers various services, such as underwriting and acting as a placement agent for public and private capital markets raising transactions; and financial advisory services in mergers and acquisitions, restructuring, and other strategic transactions, as well as institutional brokerage services and equity research services.
Featured Story: Roth IRA
Get a free copy of the Zacks research report on JMP Group (JMP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
15 Healthcare Stocks that Analysts Love
There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutical companies, medical research firms, hospital systems, and other healthcare stocks, it can be hard to identify which healthcare companies will outperform the market.
Fortunately, Wall Street’s brightest minds have already done this for us. Every year, analysts issue approximately 3,000 distinct recommendations for healthcare companies. Analysts don’t always get their “buy” ratings right, but it’s worth taking a hard look when several analysts from different brokerages and research firms are giving “strong-buy” and “buy” ratings to the same healthcare stock.
This slide show lists the 15 healthcare companies with the highest average analyst recommendations from Wall Street’s equities research analysts over the last 12 months.
